BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters

• Ngā kaituhi matua: Aris Spathis (Author), Alexander C Katoulis (Author), Vasileia Damaskou (Author), Aikaterini I. Liakou (Author), Christine Kottaridi (Author), Danai Leventakou (Author), Dimitrios Sgouros (Author), Andreas Mamantopoulos (Author), Dimitrios Rigopoulos (Author), Petros Karakitsos (Author), Ioannis G. Panayiotides (Author)
• Hōputu: Pukapuka
• I whakaputaina: Mattioli1885, 2019-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: BRAF mutations are a common finding in malignant melanoma (MM). Nevertheless, apart from their significance as a therapeutic target in advanced melanoma, their prognostic value is still debated. Objective: To assess BRAF mutation status in primary, recurrent, or metastatic MM and its cor...